Pharmaceutical Tablet Composition Comprising Eltrombopag Olamine - EP3395331

The patent EP3395331 was granted to Alfred E Tiefenbacher on Aug 21, 2019. The application was originally filed on Jul 14, 2017 under application number EP17181421A. The patent is currently recorded with a legal status of "Revoked".

EP3395331

ALFRED E TIEFENBACHER
Application Number
EP17181421A
Filing Date
Jul 14, 2017
Status
Revoked
Dec 3, 2021
Grant Date
Aug 21, 2019
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

BULLE DRMay 20, 2020KUTZENBERGERADMISSIBLE

Patent Citations (14) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONUS2010040684
DESCRIPTIONWO03098992
DESCRIPTIONWO2008136843
DESCRIPTIONWO2012121957
DESCRIPTIONWO2015121957
OPPOSITIONWO0189457
OPPOSITIONWO03098992
OPPOSITIONWO2004096154
OPPOSITIONWO2008136843
OPPOSITIONWO2012121957
OPPOSITIONWO2015029074
SEARCHWO2004096154
SEARCHWO2008136843
SEARCHWO2015029074

Non-Patent Literature (NPL) Citations (14) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference Text
OPPOSITION- Anonymous, "Bacterix 200 mg gelule nifuroxazide", Bacterix 200 mg gelule nifuroxazide, (20130618), pages 1 - 2, XP055742326
OPPOSITION- Anonymous, "furadantin tablets 50 mg summary of product characteristics", Mercury Pharmaceutical, (20140901), pages 1 - 8, XP055742337
OPPOSITION- Boylan, Et Al, "Applications in Pharmaceutical Formulation or Technology", Handbook of Pharmaceutical Excipients, (19860101), pages 161 - 162, XP055742356
OPPOSITION- G.S. Banker, Et Al, "Racemization", Modern Pharmaceutics, 4th ed. Rev. and Exp., New York, Marcel Dekker, (20020101), pages 222 - 254, XP055314922
OPPOSITION- Herbert A Lieberman, "Unknown", pharmaceutical dosage forms -- tablets 2nd edition, Marcel dekker, (19890101), pages 97 - 98, XP055742353
OPPOSITION- James Shangraw, Et Al, "Direct Cpmpressing Introduction and History", ENCYLOPEDIA OF PHARMACEUTICAL TECHNOLOGY,, (19910101), pages 85 - 106, XP055742362
OPPOSITION- Jürgen Falbe, Et Al, "Maillard-Reaktion", Römpp Chemie Lexikon, Georg Thieme Verlag, (19910101), pages 2605 - 2606, XP055742255
OPPOSITION- KUMAR V, BANKER G S, "MAILLARD REACTION AND DRUG STABILITY", MAILLARD REACTIONS IN CHEMISTRY, FOOD AND HEALTH., XX, XX, XX, (19940101), pages 20 - 27, XP008015416
OPPOSITION- L. Lachman Et Al., William C. Gunsel Et Al, "Tablets - Chapter 12", The Theory and Practice of Industrial Pharmacy, (19700101), pages 305 - 327, XP055297952
OPPOSITION- Michael E. Aulton, "SCIENTIFIC PRINCIPLES OF DOSAGE FORM DESIGN", Pharmaceutics, the science of dosage form design. 2nd Ed., Churchill Livingstone, (20020101), pages 136 - 138, XP055313168
OPPOSITION- Rudnic E M; Schwartz J D, "Chapter 45: Oral Solid Dosage Form", Rudnic E M; Schwartz J D, Gennaro A.R et al, Remington: The Science and Practice of Pharmacy, Lippincott Williams & Wilkins, (20000101), vol. 20th edition, pages 858 - 893, ISBN 978-0-683-30647-7, XP002987340
OPPOSITION- S.S. BHARATE et al., "Interactions and incompatibilities of pharmaceutical excipients with active pharmaceutical ingredients: a comprehensive review.", J. Excipients and Food Chem., (20100000), vol. 1, no. 3, pages 3 - 26, XP055131570
OPPOSITION- Sumie Yoshioka, Et Al, "Drug-Excipient and Drug-Drug Interactions", Stability of Drugs and Dosage Forms, Kluwer, (20011112), pages 29 - 33, XP055742267
OPPOSITION- T. Kunz et al, "Glucose - a Reducing Sugar? Reducing Properties of Sugars in Beverages and Food", BrewingScience, (20110701), pages 61 - 67, BrewingScience, URL: https://www.researchgate.net/publication/265915420_Glucose_-_a_Reducing_Sugar_Reducing_Properties_of_Sugars_in_Beverages_and_Food, (20201021), XP055742244

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents